Next Generation News and Research

RSS

Luminex's NxTAG Respiratory Pathogen Panel obtains FDA clearance

Luminex Corporation today announced that it has received FDA clearance for its NxTAG Respiratory Pathogen Panel that detects 20 clinically relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae and Mycoplasma pneumonia.

20 Dec 2015

New nanotechnology approach could transform gliomas from death sentence into treatable condition

An MRI contrast agent that can pass through the blood-brain barrier will allow doctors to detect deadly brain tumors called gliomas earlier, say Penn State College of Medicine researchers. This ability opens the door to make this fatal cancer treatable.

18 Dec 2015

AES Annual Meeting takes our understanding of epilepsy to next level

Epilepsy remains one of the most common neurological conditions, affecting one in 26 Americans in their lifetime, with one-third having a form of the condition that resists treatment or effective management. With those statistics in mind, more than 5,200 neurologists, scientists, nurses and health professionals came to Philadelphia December 4-8 for the 2015 American Epilepsy Society Annual Meeting to discuss new discoveries and emerging technologies that can lead to more effective treatment.

18 Dec 2015

Research opens door to validation studies in multiple tumor types of liquid biopsy

Pancreatic cancer tumors spill their molecular secrets into the blood stream, shedding their complete DNA and RNA wrapped inside protective lipid particles that make them ripe for analysis with a liquid biopsy, researchers at The University of Texas MD Anderson Cancer Center report online at the Annals of Oncology.

18 Dec 2015

Novel material can provide protection against brain injuries

Funding has been awarded to world-leading, US-based helmet designer and manufacturer, Roy Burek of Charles Owen Inc., to develop a novel material created by researchers from Cardiff University's School of Engineering that can improve the safety of athletes, members of the military and others from brain injuries by better absorbing and dissipating impact.

17 Dec 2015

National Clinician Scholars Program forms educational partnership with VA to improve health of veterans

A program launched earlier this year by UCLA and three other top research universities has formed an educational partnership with the U.S. Department of Veterans Affairs. The partnership, between the National Clinician Scholars Program and the VA, will allow the next generation of leaders and change agents to understand and improve the health of veterans, and of the nation.

16 Dec 2015

Mitochondrial variation and viable pregnancy: an interview with Dr Elpida Fragouli

Embryos require adequate amounts of energy so that they can successfully progress through each of their cell divisions.

16 Dec 2015

WuXi forms strategic alliance with MedImmune to accelerate development of biologics portfolio in China

WuXi AppTec, a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that it has formed a strategic alliance with MedImmune, the global biologics research and development arm of AstraZeneca.

16 Dec 2015

Simple diagnostic test can help fight deadly sleeping sickness

Scientists have developed a quick and simple diagnosis method, similar to a dipstick pregnancy test, to fight a deadly sleeping sickness.

16 Dec 2015

Discovery could pave way for targeted therapies to treat penile cancer

Researchers have identified potential genetic alterations in penile cancer that could pave the way for targeted treatments.

15 Dec 2015

Researchers discover first broad spectrum drug that can potently kill aging cells in culture

Researchers from the University of Arkansas for Medical Sciences and other institutions are reporting the discovery of the first broad spectrum drug that can potently kill senescent (or aging) cells in culture and effectively clear the cells in animals by specifically targeting a pathway that is critical for the survival of senescent cells.

15 Dec 2015

WaferGen Bio-systems signs collaboration agreement with Luxembourg Institute of Health

WaferGen Bio-systems announced today that the Company has signed a collaboration agreement with the Luxembourg Institute of Health, a leading public medical research center that specializes in oncology, infectious diseases, immunology, and population health.

15 Dec 2015

BTG receives 510k clearance for LC Bead LUMI

BTG plc, a global specialist healthcare company, today announced it has received 510k clearance from the US Food and Drug Administration for LC Bead LUMI, the first commercially available radiopaque embolic bead for the embolization of hypervascular tumors and arteriovenous malformations (AVMs).

14 Dec 2015

Ground breaking technology could revolutionise cancer diagnosis

A University of Warwick computer scientist is working with technology that could revolutionise how some cancers are diagnosed.

9 Dec 2015

Roche announces regulatory clearance to finalize acquisition of Kapa Biosystems

Roche today announced regulatory clearance to finalize acquisition of Kapa Biosystems, Inc., a privately-held company headquartered in Wilmington, Massachusetts, US.

8 Dec 2015

NeoGenomics introduces NeoLAB Solid Tumor Monitor, NeoLAB BTK Inhibitor Acquired Resistance test

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today an expansion of its liquid biopsy testing menu to include two new tests, a NeoLAB Solid Tumor Monitor and a NeoLAB BTK Inhibitor Acquired Resistance test.

8 Dec 2015

OncoSec reports net loss of $7.0 million for first quarter of fiscal 2016

OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced financial results for the first quarter of fiscal year ended July 31, 2016.

8 Dec 2015

New technology may facilitate early detection of sickle cell disease for infants in developing countries

Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings this weekend at the 57th Annual Meeting of the American Society of Hematology in Orlando.

8 Dec 2015

Researchers reveal potential for exploring new treatment options for triple-negative breast cancer

Researchers from Caris Life Sciences and Fox Chase Cancer Center – Temple Health announced the presentation of two studies revealing the potential for exploring new therapeutic options for triple-negative breast cancer (TNBC) at the 2015 San Antonio Breast Cancer Symposium.

7 Dec 2015

Excellence in graduate student research, third annual Kaluza prizes

Beckman Coulter collaborated with the American Society for Cell Biology to sponsor the Third Annual ASCB Kaluza Prizes for academic excellence.

From Beckman Coulter Life Sciences - Flow Cytometry 7 Dec 2015

Next Generation News and Research

Luminex's NxTAG Respiratory Pathogen Panel obtains FDA clearance

New nanotechnology approach could transform gliomas from death sentence into treatable condition

AES Annual Meeting takes our understanding of epilepsy to next level

Research opens door to validation studies in multiple tumor types of liquid biopsy

Novel material can provide protection against brain injuries

National Clinician Scholars Program forms educational partnership with VA to improve health of veterans

Mitochondrial variation and viable pregnancy: an interview with Dr Elpida Fragouli

WuXi forms strategic alliance with MedImmune to accelerate development of biologics portfolio in China

Simple diagnostic test can help fight deadly sleeping sickness

Discovery could pave way for targeted therapies to treat penile cancer

Researchers discover first broad spectrum drug that can potently kill aging cells in culture

WaferGen Bio-systems signs collaboration agreement with Luxembourg Institute of Health

BTG receives 510k clearance for LC Bead LUMI

Ground breaking technology could revolutionise cancer diagnosis

Roche announces regulatory clearance to finalize acquisition of Kapa Biosystems

NeoGenomics introduces NeoLAB Solid Tumor Monitor, NeoLAB BTK Inhibitor Acquired Resistance test

OncoSec reports net loss of $7.0 million for first quarter of fiscal 2016

New technology may facilitate early detection of sickle cell disease for infants in developing countries

Researchers reveal potential for exploring new treatment options for triple-negative breast cancer

Excellence in graduate student research, third annual Kaluza prizes

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News